Prolanta never failed, it never got off the ground. It was real at one time, but has since faded off into the sunset. It is now a fake product to keep investors attached to the hip of this sinking ship while they seek other alternatives to keep the boat afloat. Maybe they will be somewhat successful with one or two other replacements for Prolanta, but don’t bet on it, and definitely don’t invest in it.
The only thing this turd has produced for the past year is SEC filings and acquired a license for a drug to treat Osteosarcoma (which affects ONLY 800-900 patients in the US a year). No news or updates about Prolanta, their bread and butter, and a drug which began it’s clinical trial in 2016, almost 3 years ago!!!!! The last conference they were supposed to attend was June 2018 (don’t believe they made it though) and they appear to be no longer attending or planning to attend any conferences anytime soon. Webpage hasn’t been updated in months. Net cash used in operating activities for the first nine months of the year according to the last 10Q was $1,319,639, for what??????? A membership to smallcapvoice.com that only lasted a month?????? Currently $6,664,895 in debt and 254,618,074 shares can be converted and sold starting August 1, 2019.
If it looks and sounds like a con job, it probably is. Welcome to the OTC market!
Death smiles on us all. All a man can do is smile back.
